Flow cytometry analysis showed that the MDM2 inhibitor significantly induced apoptosis in PTEN-/- CRC cells in a dose-dependent manner (Figure 6A-D), with a marginal effect on PTEN+/+ CRC cells. The gene discussed is MDM2; the disease is colorectal carcinoma.